Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
suicide risk
Pharma
No evidence of suicidal risk with Novo, Lilly GLP-1s, FDA says
A preliminary evaluation by the FDA shows no evidence that use of diabetes and obesity drugs from Novo Nordisk and Lilly can cause suicidal thoughts.
Kevin Dunleavy
Jan 12, 2024 10:26am
Study says no link with Novo’s GLP-1 drugs and suicidal ideation
Jan 5, 2024 11:14am
FDA examining side-effect reports with Lilly, Novo obesity drugs
Jan 4, 2024 11:33am
EMA will monitor suicide risk in Novo Nordisk's GLP-1 products
Jul 10, 2023 11:11am
Fingerpaint Group launches 'Unf*ck Your Feelings'
Dec 1, 2022 9:45am
Appeals court tosses case over suicide linked to generic Paxil
Aug 23, 2018 11:00am